DAM represent a key microglial subpopulation present across several brain disorders and is dependent on triggering receptor expressed on myeloid cells 2-apolipoprotein E (TREM2-APOE) signaling (Krasemann et al., 2017; Keren-Shaul et al., 2017). This evidence concerns the gene APOE and brain disorder.